These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 33245961)

  • 41. NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Lin MH; Huang YP; Chang CF; Hsu CH
    Biomol NMR Assign; 2021 Apr; 15(1):137-142. PubMed ID: 33486617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
    Klemm T; Ebert G; Calleja DJ; Allison CC; Richardson LW; Bernardini JP; Lu BG; Kuchel NW; Grohmann C; Shibata Y; Gan ZY; Cooney JP; Doerflinger M; Au AE; Blackmore TR; van der Heden van Noort GJ; Geurink PP; Ovaa H; Newman J; Riboldi-Tunnicliffe A; Czabotar PE; Mitchell JP; Feltham R; Lechtenberg BC; Lowes KN; Dewson G; Pellegrini M; Lessene G; Komander D
    EMBO J; 2020 Sep; 39(18):e106275. PubMed ID: 32845033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L.
    Costanzi E; Kuzikov M; Esposito F; Albani S; Demitri N; Giabbai B; Camasta M; Tramontano E; Rossetti G; Zaliani A; Storici P
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential targets of severe acute respiratory syndrome coronavirus 2 of clinical drug fluvoxamine: Docking and molecular dynamics studies to elucidate viral action.
    Panda SK; Gupta PSS; Rana MK
    Cell Biochem Funct; 2023 Jan; 41(1):98-111. PubMed ID: 36478589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-Dimensional Visualization of Viral Structure, Entry, and Replication Underlying the Spread of SARS-CoV-2.
    Saville JW; Berezuk AM; Srivastava SS; Subramaniam S
    Chem Rev; 2022 Sep; 122(17):14066-14084. PubMed ID: 35863749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting novel structural and functional features of coronavirus protease nsp5 (3CL
    Roe MK; Junod NA; Young AR; Beachboard DC; Stobart CC
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33507143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
    Wong NA; Saier MH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
    Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
    Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An entropy-based study on mutational trajectory of SARS-CoV-2 in India.
    Santoni D; Ghosh N; Saha I
    Infect Genet Evol; 2022 Jan; 97():105154. PubMed ID: 34808395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.
    Rokić F; Trgovec-Greif L; Sučić N; Čemeljić N; Grbeša ĐC; Svedružić Ž; Rukavina T; Vugrek O; Jurak I
    Arch Virol; 2021 Jun; 166(6):1735-1739. PubMed ID: 33761008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
    Maurya SK; Maurya AK; Mishra N; Siddique HR
    J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Processing of the SARS-CoV pp1a/ab nsp7-10 region.
    Krichel B; Falke S; Hilgenfeld R; Redecke L; Uetrecht C
    Biochem J; 2020 Mar; 477(5):1009-1019. PubMed ID: 32083638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.
    Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q
    mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
    Courouble VV; Dey SK; Yadav R; Timm J; Harrison JJEK; Ruiz FX; Arnold E; Griffin PR
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1618-1630. PubMed ID: 34121407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling SARS-CoV-2 proteins in the CASP-commons experiment.
    Kryshtafovych A; Moult J; Billings WM; Della Corte D; Fidelis K; Kwon S; Olechnovič K; Seok C; Venclovas Č; Won J;
    Proteins; 2021 Dec; 89(12):1987-1996. PubMed ID: 34462960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.
    Murugan NA; Kumar S; Jeyakanthan J; Srivastava V
    Sci Rep; 2020 Nov; 10(1):19125. PubMed ID: 33154404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates.
    Prathiviraj R; Chellapandi P; Begum A; Kiran GS; Selvin J
    Virus Res; 2022 Jan; 307():198618. PubMed ID: 34740719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Updated Review on SARS-CoV-2 Main Proteinase (M
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.
    Abian O; Ortega-Alarcon D; Jimenez-Alesanco A; Ceballos-Laita L; Vega S; Reyburn HT; Rizzuti B; Velazquez-Campoy A
    Int J Biol Macromol; 2020 Dec; 164():1693-1703. PubMed ID: 32745548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.